Drug:
Reaction: INFECTION
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25139394 |
US |
75 | 2 |
Infection, Malaise, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 2 | 25139428 |
US |
1 | |
Sepsis, Hodgkin^s disease, Delirium, Infection, Limb injury, Aggression, Anaemia, Impaired healing, |
||||
VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, |
||||
| 3 | 25139530 |
US |
||
Infection, Faecaloma, Nausea, Fatigue, Dry mouth, Constipation, |
||||
ADO-TRASTUZUMAB EMTANSINE, TRASTUZUMAB, |
||||
| 4 | 25139550 |
CN |
||
Injection site reaction, Infection, Pneumonia, Urinary tract infection, |
||||
SATRALIZUMAB, |
||||
| 5 | 25139551 |
SK |
46 | 1 |
Plasma cell myeloma, Tooth disorder, Infection, |
||||
BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CISPLATIN, ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, LENALIDOMIDE, LENALIDOMIDE, MELPHALAN, MELPHALAN HYDROCHLORIDE, |
||||
| 6 | 25139907 |
US |
2 | |
Infection, Ventricular extrasystoles, Hypertension, |
||||
UPADACITINIB, PREDNISONE, |
||||
| 7 | 25140120 |
US |
80 | 2 |
Infection, |
||||
ETANERCEPT, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, PREDNISONE, |
||||
| 8 | 25140225 |
US |
2 | |
Infection, Drug ineffective, |
||||
RITUXIMAB, DABIGATRAN ETEXILATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 9 | 25140227 |
ES |
84 | 1 |
Cytopenia, Gait inability, Infection, Injection site discolouration, Injection site pain, |
||||
DUPILUMAB, |
||||
| 10 | 25140252 |
US |
50 | 1 |
Small intestinal obstruction, Sepsis, Hypotension, Illness, Gallbladder disorder, Infection, Pyrexia, Infection, Fungal infection, |
||||
RIOCIGUAT, RIOCIGUAT, RIOCIGUAT, TREPROSTINIL, TREPROSTINIL, AMBRISENTAN, TREPROSTINIL, NITRIC OXIDE, AMBRISENTAN, |
||||
| 11 | 25140259 |
US |
210 | 1 |
Therapy partial responder, Myelosuppression, Febrile neutropenia, Infection, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, ETOPOSIDE, |
||||
| 12 | 25140260 |
US |
107 | 1 |
Disease progression, Drug ineffective, Myelosuppression, Febrile neutropenia, Infection, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, ETOPOSIDE, |
||||
| 13 | 25140275 |
US |
119 | 1 |
Septic shock, Myelosuppression, Febrile neutropenia, Sepsis, Infection, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, ETOPOSIDE, |
||||
| 14 | 25140277 |
US |
53 | 2 |
Therapy partial responder, Septic shock, Myelosuppression, Febrile neutropenia, Sepsis, Infection, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, TEMOZOLOMIDE, |
||||
| 15 | 25140549 |
JP |
8 | 2 |
Hepatic infarction, Liver abscess, Biloma, Infection, |
||||
ETHIODIZED OIL, |
||||
| 16 | 25140654 |
IN |
26 | 2 |
Infection, Hypervolaemia, |
||||
ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
| 17 | 25140789 |
1 | ||
Infective pulmonary exacerbation of cystic fibrosis, Infection, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 18 | 25141807 |
CA |
||
Asthenia, Infection, Lower respiratory tract infection, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 19 | 25142177 |
US |
2 | |
Colitis ulcerative, Impaired quality of life, Diarrhoea, Infection, Skin irritation, Drug ineffective, Alopecia, Product dose omission issue, Trichorrhexis, Memory impairment, Abdominal pain, Injection site erythema, Respiratory tract infection, Rash, Headache, Fatigue, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, NORELGESTROMIN AND ETHINYL ESTRADIOL, BUDESONIDE, METHYLPHENIDATE HYDROCHLORIDE, LISDEXAMFETAMINE DIMESYLATE, SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
| 20 | 25144797 |
79 | 2 | |
Oral herpes, Infection, |
||||
TOCILIZUMAB, |
||||
| 21 | 25145002 |
56 | 2 | |
Vulvovaginal swelling, Vaginal haemorrhage, Infection, Vaginal mucosal blistering, Vulvovaginal injury, Toxicity to various agents, Weight decreased, Rash vesicular, Skin exfoliation, Optic ischaemic neuropathy, Blindness, Bladder disorder, Scar, Urethral obstruction, Post procedural complication, Sexual dysfunction, Feeding disorder, |
||||
IPILIMUMAB, NIVOLUMAB, ERGOCALCIFEROL, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, PANTOPRAZOLE, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 22 | 25138747 |
DE |
45 | 2 |
Infection, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 23 | 25137164 |
US |
50 | 2 |
Spinal laminectomy, Infection, Procedural site reaction, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 24 | 25137173 |
FR |
79 | 1 |
General physical health deterioration, Infection, Lung disorder, |
||||
| 25 | 25137179 |
GB |
76 | 1 |
Hypotension, Aortic aneurysm, Tremor, Cellulitis, Therapeutic product effect variable, Atrial fibrillation, Infection, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, LEVOTHYROXINE, PRAMIPEXOLE, OPICAPONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MIRABEGRON, RAMIPRIL, RAMIPRIL, |
||||
| 26 | 25137530 |
AU |
27 | 2 |
Infection, Renal failure, Drug ineffective, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ENALAPRIL, FUROSEMIDE, METHYLDOPA, |
||||
| 27 | 25137558 |
US |
70 | 2 |
Infection, |
||||
LENALIDOMIDE, |
||||
| 28 | 25137639 |
US |
92 | 1 |
Peripheral swelling, Infection, |
||||
LENALIDOMIDE, |
||||
| 29 | 25137687 |
PL |
||
Sudden death, Infection, Oedema peripheral, Circulatory collapse, Fatigue, Infection parasitic, Cardiac failure, Neoplasm malignant, Vomiting, Hyponatraemia, Thrombocytopenia, Arthralgia, Urinary tract infection, Diarrhoea, Constipation, Pyrexia, Chills, Neutropenia, Sinus node dysfunction, Febrile neutropenia, Arrhythmia, Tumour lysis syndrome, Nausea, Anaemia, Cardiac arrest, Decreased appetite, Epistaxis, Hyperphosphataemia, Arthralgia, Upper respiratory tract infection, Ischaemic stroke, Cough, Pneumonia, Cholestasis, Atrial fibrillation, Rash, |
||||
IBRUTINIB, VENETOCLAX, |
||||
| 30 | 25132528 |
1 | ||
Application site irritation, Infection, |
||||
KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, |
||||
| 31 | 25132714 |
CN |
47 | |
Hypothyroidism, Hepatotoxicity, Flushing, Rash, Infection, |
||||
| 32 | 25132893 |
ES |
||
Atrial fibrillation, Diarrhoea, Neutropenia, Infection, Hypertension, Toxicity to various agents, Nausea, |
||||
IBRUTINIB, VENETOCLAX, |
||||
| 33 | 25133430 |
CN |
52 | 2 |
Pneumocystis jirovecii pneumonia, Epstein-Barr virus infection, Cough, Infection, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 34 | 25133462 |
PL |
42 | 2 |
Gastrointestinal fistula, Stoma site ulcer, Intestinal fistula, Diarrhoea haemorrhagic, Infected fistula, Clostridium difficile infection, Post procedural fistula, Endocarditis bacterial, Abscess intestinal, Proctitis, Drug ineffective, Anastomotic fistula, Anastomotic leak, Stoma site haemorrhage, Pelvic abscess, Infection, White blood cell count increased, Drug specific antibody present, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 35 | 25133527 |
ES |
||
Thrombocytopenia, Neutropenia, Leukopenia, Neuropathy peripheral, Unevaluable event, Insomnia, Off label use, Stress, Anxiety, Cough, Dyspnoea, Weight decreased, Anaemia, Chest pain, Fatigue, Nausea, Decreased appetite, Constipation, Vomiting, Ageusia, Alopecia, Mucosal inflammation, Oral pain, Depression, Dry skin, Dry mouth, Diarrhoea, Pyrexia, Influenza like illness, Myalgia, Rash, Arthralgia, Dyspnoea, Fluid retention, Abdominal pain, Headache, Mood altered, Infection, |
||||
DENOSUMAB, BEVACIZUMAB, |
||||
| 36 | 25133535 |
US |
||
Febrile neutropenia, Myelosuppression, Infection, |
||||
TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, |
||||
| 37 | 25133551 |
CA |
||
White blood cell count increased, Rheumatic fever, X-ray abnormal, Lung disorder, Laryngitis, Grip strength, Pneumonia, Visual impairment, Stomatitis, Weight increased, Joint range of motion decreased, Bone erosion, Irritable bowel syndrome, Lupus-like syndrome, Systemic lupus erythematosus, Muscle injury, Impaired healing, Dyspnoea, Hepatic enzyme increased, Abdominal pain upper, Headache, Oedema, Loss of personal independence in daily activities, Dizziness, Night sweats, Weight fluctuation, Swollen joint count increased, Pancreatitis, Rectal haemorrhage, Rheumatoid arthritis, Decreased appetite, Obesity, Laboratory test abnormal, Weight decreased, Diarrhoea, Gait disturbance, Glossodynia, Hand deformity, Exostosis, Mobility decreased, Liver disorder, Musculoskeletal stiffness, Sciatica, General physical health deterioration, Adjustment disorder with depressed mood, Depression, Arthritis, Facet joint syndrome, Insomnia, Lip dry, Vomiting, Discomfort, Hepatic cirrhosis, Folliculitis, Inflammation, Pyrexia, Liver injury, Autoimmune disorder, Anti-cyclic citrullinated peptide antibody positive, Peripheral swelling, Oedema peripheral, Pain, Fibromyalgia, Wound, Hypoaesthesia, Condition aggravated, Gastrointestinal disorder, Nasopharyngitis, Feeling hot, Memory impairment, Delirium, Swollen joint count, Breast cancer stage III, Asthma, Porphyria acute, Paraesthesia, Foot deformity, Wheezing, Synovitis, Ill-defined disorder, Arthralgia, Dry mouth, Crohn^s disease, Muscle spasms, Muscular weakness, Rash, Chest pain, Contusion, Infusion related reaction, Peripheral venous disease, Rheumatoid factor positive, Duodenal ulcer perforation, Migraine, Abdominal discomfort, Hypertension, Osteoarthritis, Sinusitis, Pruritus, Grip strength decreased, Asthenia, Type 2 diabetes mellitus, Fatigue, Musculoskeletal pain, Sleep disorder due to general medical condition, insomnia type, Pemphigus, Sleep disorder due to a general medical condition, Abdominal pain, Pulmonary fibrosis, C-reactive protein abnormal, Blood cholesterol increased, Hypersensitivity, Nausea, Joint swelling, Arthropathy, Swelling, Blister, Walking aid user, Drug hypersensitivity, Amnesia, Retinitis, Bursitis, Osteoporosis, Anxiety, Dyspepsia, Frequent bowel movements, Urticaria, Hypercholesterolaemia, Injury, Colitis ulcerative, Psoriatic arthropathy, Malaise, Lupus vulgaris, Confusional state, Dislocation of vertebra, Road traffic accident, Alopecia, Pericarditis, Infection, Ear infection, Lower respiratory tract infection, Wound infection, Helicobacter infection, Maternal exposure during pregnancy, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, SECUKINUMAB, SECUKINUMAB, RAMIPRIL, LISINOPRIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ERYTHROMYCIN, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROXYCHLOROQUINE SULFATE, LANSOPRAZOLE, ERGOCALCIFEROL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, TOCILIZUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, APREMILAST, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREGABALIN, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREGABALIN, HYALURONIDASE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LEFLUNOMIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DESOXIMETASONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LORAZEPAM, FLUOROMETHOLONE, SULFASALAZINE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, MESALAMINE, TOFACITINIB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, RITUXIMAB, RITUXIMAB, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, CAFFEINE, MELOXICAM, MORPHINE, MAGNESIUM, USTEKINUMAB, TOFACITINIB, TOFACITINIB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LANSOPRAZOLE, INFLIXIMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, CALCIUM CARBONATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, SECUKINUMAB, |
||||
| 38 | 25133608 |
GB |
71 | 1 |
Chronic obstructive pulmonary disease, Infection, |
||||
USTEKINUMAB-TTWE, |
||||
| 39 | 25133768 |
IN |
46 | 1 |
Lower limb fracture, Infection, Peritoneal cloudy effluent, |
||||
| 40 | 25134103 |
HU |
60 | 2 |
Blindness, Disorientation, Infection, |
||||
OCRELIZUMAB, |
||||
| 41 | 25134489 |
US |
71 | 1 |
Infection, White blood cell count increased, |
||||
LECANEMAB, |
||||
| 42 | 25134514 |
US |
1 | |
Gastrostomy, Aspiration, Pneumonia, Infection, Product dose omission issue, |
||||
VAMOROLONE, LEVETIRACETAM, LACOSAMIDE, ERGOCALCIFEROL, HYDROXYZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ALBUTEROL SULFATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, GOLODIRSEN, |
||||
| 43 | 25134561 |
CA |
21 | 2 |
Ovarian cyst, Endometrial adenocarcinoma, Exposure during pregnancy, Nausea, Hydronephrosis, Nephrolithiasis, Disease complication, Caesarean section, Dehydration, Procedural pain, Weight decreased, Fatigue, Constipation, Infection, Food aversion, Inappropriate schedule of product administration, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 44 | 25134914 |
US |
16 | 1 |
Hospitalisation, Infection, Dehydration, Pyrexia, |
||||
DUPILUMAB, |
||||
| 45 | 25135208 |
US |
60 | 1 |
Condition aggravated, Infection, Pseudomonas infection, Staphylococcal infection, Sleep disorder, Loss of personal independence in daily activities, |
||||
ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, TADALAFIL, PANCRELIPASE, MOMETASONE FUROATE, MOMETASONE, INSULIN LISPRO, INSULIN GLARGINE, ESCITALOPRAM, METHOCARBAMOL, METHOCARBAMOL TABLETS, POLYETHYLENE GLYCOL 3350, OMEPRAZOLE MAGNESIUM, FINASTERIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, BUPROPION HYDROCHLORIDE, ALPRAZOLAM, |
||||
| 46 | 25135243 |
SK |
1 | |
Infection, Thrombocytopenia, Skin toxicity, Swelling face, Rash pruritic, |
||||
LONCASTUXIMAB TESIRINE, LONCASTUXIMAB TESIRINE, LONCASTUXIMAB TESIRINE, |
||||
| 47 | 25135308 |
US |
66 | 1 |
Erythema, Skin mass, Infection, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 48 | 25135850 |
CA |
||
Infection, |
||||
RAVULIZUMAB, RAVULIZUMAB, |
||||
| 49 | 25136001 |
US |
61 | 2 |
Infection, Peripheral swelling, Injection site bruising, |
||||
AVATROMBOPAG MALEATE, AVATROMBOPAG MALEATE, EPINEPHRINE, ADRENALINUM, |
||||
| 50 | 25136127 |
JP |
||
Infection, |
||||
GOLIMUMAB, |
||||
| 51 | 25136392 |
DE |
74 | 1 |
Pneumonia, Infection, Coma, Metabolic acidosis, |
||||
EMPAGLIFLOZIN, |
||||
| 52 | 25136687 |
DE |
62 | 2 |
Syncope, Infection, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CARFILZOMIB, CARFILZOMIB, CARFILZOMIB, CARFILZOMIB, LENALIDOMIDE, ACYCLOVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ENOXAPARIN SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 53 | 25137055 |
CA |
2 | |
Intervertebral disc protrusion, Infection, |
||||
UPADACITINIB, |
||||
| 54 | 25140575 |
38 | 1 | |
Infection, |
||||
ADALIMUMAB, |
||||
| 55 | 25140576 |
73 | 2 | |
Infection, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 56 | 25126523 |
US |
||
Illness, Infection, Pulmonary thrombosis, Thrombosis, Pericardial effusion, Intra-abdominal fluid collection, |
||||
ECULIZUMAB, |
||||
| 57 | 25126529 |
FR |
62 | |
Cushing^s syndrome, Pneumonia, Infection, Hypogammaglobulinaemia, Hypoglobulinaemia, Lung disorder, |
||||
SAXAGLIPTIN, VERAPAMIL HYDROCHLORIDE, LANSOPRAZOLE, CLOPIDOGREL, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, FUROSEMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 58 | 25126838 |
CN |
||
Infection, Pyrexia, Chronic obstructive pulmonary disease, Respiratory failure, Infective exacerbation of bronchiectasis, Respiratory disorder, Streptococcal infection, Off label use, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, OXYGEN, 0XYGEN, |
||||
| 59 | 25126974 |
US |
2 | |
Injection site swelling, Infection, Drug ineffective, Product dose omission issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 60 | 25127051 |
US |
2 | |
Discomfort, Infection, Diarrhoea, Fatigue, Pyrexia, Arthralgia, Off label use, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, HYDROXYCHLOROQUINE, LOSARTAN POTASSIUM, LOSARTAN, NAPROXEN, NAPROXEN SODIUM, SULFASALAZINE, IXEKIZUMAB, |
||||
| 61 | 25127114 |
US |
2 | |
Skin lesion, Infection, Arthralgia, |
||||
BIMEKIZUMAB, CYCLOBENZAPRINE, METHYLPREDNISOLONE ACETATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), FISH OIL, FOLIC ACID, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 62 | 25127168 |
TN |
||
Sepsis, Endocarditis, Skin infection, Respiratory tract infection, Urinary tract infection, Ear, nose and throat infection, Off label use, Infection, |
||||
INFLIXIMAB, ADALIMUMAB-AACF, ADALIMUMAB, ETANERCEPT, TOCILIZUMAB, RITUXIMAB, |
||||
| 63 | 25127264 |
CA |
2 | |
Ear operation, Pain, Infection, |
||||
ZOLEDRONIC ACID, |
||||
| 64 | 25127293 |
US |
39 | 2 |
Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Uterine scar, Emotional disorder, Infection, |
||||
COPPER, |
||||
| 65 | 25127298 |
US |
41 | 2 |
Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Embedded device, Emotional disorder, Infection, Pain, Abnormal uterine bleeding, Dysmenorrhoea, |
||||
COPPER, |
||||
| 66 | 25127400 |
US |
69 | 1 |
Renal mass, Infection, Incision site haemorrhage, Postoperative wound infection, Unevaluable event, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 67 | 25127449 |
JP |
50 | 1 |
Infection, |
||||
ZOLBETUXIMAB, FLUOROURACIL, OXALIPLATIN, LEVOLEUCOVORIN INJECTION, LEVOLEUCOVORIN CALCIUM, LEVOLEUCOVORIN, |
||||
| 68 | 25127526 |
US |
||
Septic shock, Infection, Dysphagia, Metastases to skin, |
||||
CAPIVASERTIB, |
||||
| 69 | 25127585 |
CA |
75 | 1 |
Infection, Walking aid user, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 70 | 25127723 |
US |
33 | 1 |
Pain, Discomfort, Erythema, Infection, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 71 | 25127994 |
DE |
82 | 1 |
Musculoskeletal stiffness, Condition aggravated, Infection, |
||||
CLOZAPINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FOLIC ACID, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 72 | 25128113 |
US |
80 | 1 |
Infection, |
||||
ZILUCOPLAN, ALLOPURINOL, AMLODIPINE, CALCIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), ENALAPRIL, FENOFIBRATE, FLUTICASONE PROPIONATE, FUROSEMIDE, INSULIN ASPART, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, PROPRANOLOL HYDROCHLORIDE, ROSUVASTATIN, ICOSAPENT ETHYL, ERGOCALCIFEROL, WARFARIN, |
||||
| 73 | 25128117 |
JP |
||
Infection, |
||||
LUSPATERCEPT, |
||||
| 74 | 25128151 |
DE |
35 | 1 |
Infection, Acute graft versus host disease in intestine, Acute graft versus host disease in skin, Acute graft versus host disease in skin, Drug ineffective, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RITUXIMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TREOSULFAN, HYDROXYUREA, |
||||
| 75 | 25128270 |
DE |
35 | 1 |
Drug ineffective, Acute graft versus host disease in intestine, Acute graft versus host disease in skin, Acute graft versus host disease in skin, Infection, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, FLUDARABINE PHOSPHATE, TREOSULFAN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, HYDROXYUREA, |
||||
| 76 | 25128342 |
CA |
||
Condition aggravated, Infection, Exposure to SARS-CoV-2, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, CALCIUM, PREDNISONE, |
||||
| 77 | 25128603 |
US |
119 | 1 |
Septic shock, Myelosuppression, Infection, Febrile neutropenia, Sepsis, |
||||
TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CISPLATIN, ETOPOSIDE, CARBOPLATIN, THIOTEPA, LOMUSTINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 78 | 25128605 |
US |
53 | 2 |
Sepsis, Septic shock, Myelosuppression, Infection, Febrile neutropenia, |
||||
TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CISPLATIN, ETOPOSIDE, METHOTREXATE, METHOTREXATE SODIUM, CARBOPLATIN, THIOTEPA, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, ETOPOSIDE, |
||||
| 79 | 25128937 |
2 | ||
Drug ineffective, Pain, Therapy interrupted, Infection, Illness, |
||||
ETANERCEPT, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CALCIUM CARBONATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 80 | 25129019 |
RU |
||
Pneumonia, Herpes virus infection, Adverse event, Infection, Hypersensitivity, Off label use, Drug ineffective, |
||||
GOLIMUMAB, INFLIXIMAB, |
||||
| 81 | 25129134 |
US |
55 | 2 |
Nausea, Infection, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METHOTREXATE SODIUM, FOLIC ACID, PREDNISONE, ALBUTEROL SULFATE, TRAMADOL HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE, AZELASTINE, AMLODIPINE BESYLATE, RITUXIMAB, LEVOCETIRIZINE DIHYDROCHLORIDE, OLMESARTAN MEDOXOMIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DICLOFENAC SODIUM, |
||||
| 82 | 25129158 |
2 | ||
Infection, Fatigue, Asthma, |
||||
MEPOLIZUMAB, PREDNISONE, |
||||
| 83 | 25129261 |
CA |
86 | 2 |
Breast cancer, Erythema, Abdominal distension, Herpes zoster, Infection, Diarrhoea, |
||||
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, MEPOLIZUMAB, ALBUTEROL SULFATE, |
||||
| 84 | 25129399 |
US |
||
Acute hepatic failure, Toxicity to various agents, Arrhythmia, Infection, Septic shock, Gastrointestinal haemorrhage, Haemorrhage, Brain oedema, Seizure, Acute respiratory distress syndrome, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 85 | 25129451 |
CA |
74 | 2 |
Illness, Influenza like illness, Oropharyngeal pain, Skin cancer, Infection, |
||||
ETANERCEPT, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, DEXLANSOPRAZOLE, EZETIMIBE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN CALCIUM, |
||||
| 86 | 25129528 |
US |
||
Acute hepatic failure, Toxicity to various agents, Arrhythmia, Infection, Septic shock, Gastrointestinal haemorrhage, Haemorrhage, Brain oedema, Seizure, Acute respiratory distress syndrome, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 87 | 25129660 |
GB |
38 | 1 |
Infection, |
||||
RITLECITINIB, |
||||
| 88 | 25129851 |
US |
49 | 2 |
Cough, Diarrhoea, Infection, |
||||
ELTROMBOPAG OLAMINE, |
||||
| 89 | 25129933 |
75 | 2 | |
Infection, Therapy interrupted, |
||||
APREMILAST, |
||||
| 90 | 25129990 |
GB |
40 | 2 |
Spinal osteoarthritis, Influenza, Abscess, Liver disorder, Infection, General physical health deterioration, Product use in unapproved indication, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 91 | 25130061 |
US |
80 | 2 |
Infection, Dyspnoea, Lung disorder, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 92 | 25130152 |
US |
53 | 2 |
Rheumatoid arthritis, Infection, |
||||
ABATACEPT, |
||||
| 93 | 25130435 |
IT |
||
Infection, Cardiac failure, Haematoma, Atrial fibrillation, Anaemia, |
||||
ACALABRUTINIB, |
||||
| 94 | 25130482 |
JP |
6 | 2 |
Infection, Pyrexia, |
||||
TOCILIZUMAB, |
||||
| 95 | 25130572 |
US |
1 | |
Sepsis, Hodgkin^s disease, Delirium, Infection, Limb injury, Aggression, Anaemia, Impaired healing, |
||||
VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, |
||||
| 96 | 25130611 |
CN |
4 | 1 |
Liver injury, Hepatic enzyme increased, Myelosuppression, Pyrexia, Infection, |
||||
IFOSFAMIDE, ETOPOSIDE, CYTARABINE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 97 | 25130773 |
CA |
||
Addison^s disease, Asthma, Dyspnoea, Infection, Loss of personal independence in daily activities, Productive cough, Sleep disorder due to a general medical condition, Therapeutic product effect incomplete, Wheezing, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, MEPOLIZUMAB, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ERGOCALCIFEROL, LORAZEPAM, MENADIONE, PREDNISONE, PREDNISONE, TIOTROPIUM BROMIDE, TOBRAMYCIN SULFATE, CEFTAZIDIME, METHYLPREDNISOLONE, PANCRELIPASE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 98 | 25130787 |
CA |
||
Psoriasis, Pruritus, Contusion, Subcutaneous drug absorption impaired, Confusional state, Infusion related reaction, Blood cholesterol increased, Abdominal discomfort, Back disorder, Peripheral swelling, Depression, Glossodynia, Musculoskeletal stiffness, Folliculitis, Pyrexia, Muscle injury, Chest pain, Pustular psoriasis, Adjustment disorder with depressed mood, Oedema, Duodenal ulcer perforation, Injury, Myositis, Malaise, Fibromyalgia, Joint swelling, Gait disturbance, Pulmonary fibrosis, Impaired healing, Blister, Dislocation of vertebra, Gait inability, Fatigue, Anti-cyclic citrullinated peptide antibody positive, Breast cancer stage II, Amnesia, Mobility decreased, Rheumatoid arthritis, Lower respiratory tract infection, Sleep disorder, Delirium, Systemic lupus erythematosus, Rheumatoid factor positive, General symptom, Weight increased, Decreased appetite, Hypoaesthesia, Pneumonia, Abdominal pain upper, Sleep disorder due to general medical condition, insomnia type, Swollen joint count increased, Joint range of motion decreased, Hand deformity, Grip strength decreased, Swelling, X-ray abnormal, Dyspepsia, Weight decreased, Type 2 diabetes mellitus, Disability, Hepatic enzyme increased, Pemphigus, Condition aggravated, Dyspnoea, Urticaria, Hypertension, Gastrointestinal disorder, Wound, Arthropathy, Liver injury, Stomatitis, Fluid retention, Arthralgia, Hypercholesterolaemia, Discomfort, Migraine, General physical health deterioration, Ill-defined disorder, Psoriatic arthropathy, Wheezing, Pain in extremity, Rheumatic fever, Memory impairment, Rash vesicular, Alopecia, Nasopharyngitis, Diarrhoea, Nausea, Wound infection, Vomiting, Headache, Hypersensitivity, Helicobacter infection, Infection, Irritable bowel syndrome, Synovitis, Sinusitis, Pericarditis, Pain, Rash, Drug hypersensitivity, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ALENDRONATE SODIUM, CALCIUM CARBONATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, VEDOLIZUMAB, CERTOLIZUMAB PEGOL, ADALIMUMAB, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, INFLIXIMAB, ADALIMUMAB, GOLIMUMAB, PHENYLEPHRINE HYDROCHLORIDE, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, USTEKINUMAB, GOLIMUMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, FOLIC ACID, FOLIC ACID, FOLIC ACID, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, VITAMIN C, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, PREDNISONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, APREMILAST, RITUXIMAB, LORAZEPAM, CAFFEINE CITRATE, CALCIUM GLUCONATE, SECUKINUMAB, SECUKINUMAB, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 99 | 25131042 |
CN |
36 | 2 |
Coma, Somnolence, Craniocerebral injury, Gastrointestinal haemorrhage, Cerebral infarction, Myocardial ischaemia, B-cell type acute leukaemia, Cerebral haemorrhage, Systemic inflammatory response syndrome, Brain herniation, Electrolyte imbalance, Diarrhoea, Platelet count decreased, Infection, |
||||
TIGECYCLINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE, MEROPENEM, VANCOMYCIN HYDROCHLORIDE, ERAVACYCLINE, |
||||
| 100 | 25131098 |
CO |
52 | 2 |
Infection, |
||||
METYRAPONE, LOSARTAN, AMLODIPINE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, SPIRONOLACTONE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28